CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 56 filers reported holding CASI PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $133,000 | +329.0% | 45,064 | +121.5% | 0.00% | – |
| Q3 2020 | $31,000 | -65.9% | 20,343 | -44.7% | 0.00% | – |
| Q2 2020 | $91,000 | +16.7% | 36,806 | -3.9% | 0.00% | – |
| Q1 2020 | $78,000 | -27.8% | 38,297 | +10.0% | 0.00% | – |
| Q4 2019 | $108,000 | -13.6% | 34,803 | -8.0% | 0.00% | – |
| Q3 2019 | $125,000 | +3.3% | 37,827 | 0.0% | 0.00% | – |
| Q2 2019 | $121,000 | +18.6% | 37,827 | +5.5% | 0.00% | – |
| Q1 2019 | $102,000 | -20.3% | 35,867 | +12.3% | 0.00% | – |
| Q4 2018 | $128,000 | -22.4% | 31,943 | -9.3% | 0.00% | – |
| Q3 2018 | $165,000 | -50.6% | 35,227 | -13.3% | 0.00% | – |
| Q2 2018 | $334,000 | +2936.4% | 40,614 | +1389.9% | 0.00% | – |
| Q1 2018 | $11,000 | +22.2% | 2,726 | -5.1% | 0.00% | – |
| Q4 2017 | $9,000 | +800.0% | 2,871 | +251.8% | 0.00% | – |
| Q3 2014 | $1,000 | – | 816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,934,000 | 16.36% |
| Wellington Shields & Co., LLC | 1,585,609 | $3,964,000 | 1.74% |
| Wellington Shields Capital Management, LLC | 1,321,745 | $3,304,000 | 0.53% |
| Ikarian Capital, LLC | 1,039,910 | $2,600,000 | 0.21% |
| Zebra Capital Management LLC | 50,658 | $127,000 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 139,183 | $348,000 | 0.02% |
| Manatuck Hill Partners, LLC | 15,090 | $38,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 205,200 | $513,000 | 0.01% |
| IHT Wealth Management, LLC | 26,000 | $65,000 | 0.01% |
| Vident Investment Advisory, LLC | 67,540 | $169,000 | 0.01% |